These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 31144314)

  • 1. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches.
    Yang C; Kim HS; Song G; Lim W
    J Cell Physiol; 2019 Dec; 234(12):21493-21503. PubMed ID: 31144314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of exosomal non‑coding RNAs in ovarian cancer (Review).
    Wang X; Yang M; Zhu J; Zhou Y; Li G
    Int J Mol Med; 2024 Oct; 54(4):. PubMed ID: 39129308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Exosomal microRNAs and Proteins in Ovarian Cancer Diagnosis, Prognosis, and Treatment.
    Qin T; Chen F; Zhu J; Ding Y; Zhang Q
    Curr Mol Med; 2023; 23(6):509-520. PubMed ID: 35770407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
    Fanale D; Corsini LR; Bono M; Randazzo U; Barraco N; Brando C; Cancelliere D; Contino S; Giurintano A; Magrin L; Pedone E; Perez A; Piraino P; Pivetti A; Giovanni ED; Russo TDB; Prestifilippo O; Gennusa V; Pantuso G; Russo A; Bazan V
    Crit Rev Oncol Hematol; 2024 Jan; 193():104220. PubMed ID: 38036154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
    Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
    Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNAs as biomarkers of ovarian cancer.
    Zhang H; Lu B
    Expert Rev Anticancer Ther; 2020 May; 20(5):373-385. PubMed ID: 32326768
    [No Abstract]   [Full Text] [Related]  

  • 7. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer.
    Li X; Wang X
    Mol Cancer; 2017 May; 16(1):92. PubMed ID: 28506269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
    Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
    EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
    J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
    Cheng L; Wu S; Zhang K; Qing Y; Xu T
    J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal lncRNAs and cancer: connecting the missing links.
    Naderi-Meshkin H; Lai X; Amirkhah R; Vera J; Rasko JEJ; Schmitz U
    Bioinformatics; 2019 Jan; 35(2):352-360. PubMed ID: 30649349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
    Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer exosomes initiate global long non-coding RNA changes in mesenchymal stem cells.
    Wang S; Li X; Zhu R; Han Q; Zhao RC
    Int J Oncol; 2016 Feb; 48(2):681-9. PubMed ID: 26648258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
    Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
    Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes and exosomal RNAs in breast cancer: A status update.
    Lakshmi S; Hughes TA; Priya S
    Eur J Cancer; 2021 Feb; 144():252-268. PubMed ID: 33373870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
    Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
    J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimicking the tumor microenvironment: Fibroblasts reduce miR-29b expression and increase the motility of ovarian cancer cells in a co-culture model.
    Medeiros M; Ribeiro AO; Lupi LA; Romualdo GR; Pinhal D; Chuffa LGA; Delella FK
    Biochem Biophys Res Commun; 2019 Aug; 516(1):96-101. PubMed ID: 31200958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role and Applications of Exosomes in Gynecological Cancer: A Review.
    Wang KH; Ding DC
    Cell Transplant; 2023; 32():9636897231195240. PubMed ID: 37632354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.